Home » Topics » BioWorld Science

BioWorld Science
RSS

First patients imaged in phase II expanded access study of 68Ga-PSMA-11

Aug. 13, 2018

Samsung Bioepis to soon begin phase I study of SB-26

Aug. 13, 2018

FDA approves The Population Council's 1-year contraceptive Annovera

Aug. 13, 2018

PARP inhibitors may be ALS drugs

Aug. 13, 2018

Researchers identify novel candidate genes involved in cognitive function

Aug. 13, 2018

Progranulin as a novel therapeutic target for the treatment of frontotemporal dementia

Aug. 13, 2018

Controlling HIV's reservoir

Aug. 13, 2018

TRK fusions actionable in blood cancers

Aug. 13, 2018

Preventing fat uptake by lymphatic system could be antiobesity approach

Aug. 13, 2018

MAP3K5 inhibitors identified by Fujian Cosunter Pharmaceutical Co., Medshine Discovery

Aug. 13, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...